Comment on

• Lymphocyte subpopulations in the skin of patients with chronic urticaria.

  Mekori YA, Giorno RC, Anderson P, Kohler PF. Mekori YA, et al. J Allergy Clin Immunol. 1983 Dec;72(6):681-4. doi: 10.1016/0091-6749(83)90629-2. J Allergy Clin Immunol. 1983. PMID: 6227650
• Chronic urticaria sera increase basophil CD203c expression.

  Yasnowsky KM, Dreskin SC, Efaw B, Schoen D, Vedanthan PK, Alam R, Harbeck RJ. Yasnowsky KM, et al. J Allergy Clin Immunol. 2006 Jun;117(6):1430-4. doi: 10.1016/j.jaci.2006.02.016. Epub 2006 Apr 27. J Allergy Clin Immunol. 2006. PMID: 16751009
• Treatment of chronic autoimmune urticaria with omalizumab.

  Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK. Kaplan AP, et al. J Allergy Clin Immunol. 2008 Sep;122(3):569-73. doi: 10.1016/j.jaci.2008.07.006. J Allergy Clin Immunol. 2008. PMID: 18774392 Clinical Trial.
• Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria.

  Arkwright PD. Arkwright PD. J Allergy Clin Immunol. 2009 Feb;123(2):510-1; author reply 511. doi: 10.1016/j.jaci.2008.11.043. J Allergy Clin Immunol. 2009. PMID: 19203667 No abstract available.
• Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.

  Maurer M, Altrichter S, Bieber T, Biedermann T, Bräutigam M, Seyfried S, Brehler R, Grabbe J, Hunzelmann N, Jakob T, Jung A, Kleine-Tebbe J, Mempel M, Meurer M, Reich K, Ruëff F, Schäkel K, Sengupta K, Sieder C, Simon JC, Wedi B, Zuberbier T, Mahler V, Staubach P. Maurer M, et al. J Allergy Clin Immunol. 2011 Jul;128(1):202-209.e5. doi: 10.1016/j.jaci.2011.04.038. Epub 2011 Jun 2. J Allergy Clin Immunol. 2011. PMID: 21636116 Clinical Trial.